MORGAN STANLEY PLC/CALL/AMGEN/360/0.1/17.01.25 Stock

Warrant

DE000MB0BQK5

Market Closed - Börse Stuttgart 14:19:40 2024-07-05 EDT
0.96 EUR +6.67% Intraday chart for MORGAN STANLEY PLC/CALL/AMGEN/360/0.1/17.01.25
Current month-7.69%
1 month-13.51%
Date Price Change
24-07-05 0.96 +6.67%
24-07-04 0.9 0.00%
24-07-03 0.9 -9.09%
24-07-02 0.99 -1.00%
24-07-01 1 -3.85%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 02:19 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying AMGEN INC.
Issuer Morgan Stanley
WKN MB0BQK
ISINDE000MB0BQK5
Date issued 2022-11-09
Strike 360 $
Maturity 2025-01-17 (195 Days)
Parity 10 : 1
Emission price 2.42
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.68
Lowest since issue 0.2
Delta0.29x
Omega 8.462
Premium19.27x
Gearing28.82x
Moneyness 0.8636
Difference Strike 49.12 $
Difference Strike %+13.64%
Spread 0.05
Spread %4.90%
Theoretical value 0.9950
Implied Volatility 28.29 %
Total Loss Probability 76.98 %
Intrinsic value 0.000000
Present value 0.9950
Break even 370.79 €
Theta-0.04x
Vega0.07x
Rho0.04x

Company Profile

Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other (5.8%): primarily royalties. The United States account for 70.3% of net sales.
Sector
-
More about the company

Ratings for Amgen Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Amgen Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.9 USD
Average target price
316.4 USD
Spread / Average Target
+1.79%
Consensus